Advances in Mast Cell Targeted Therapies for Chronic Hives
Over the past 35 years, the mast cell's pivotal role in chronic urticaria (hives) has been well-established in medical and scientific research. Despite this knowledge, initial therapeutic advances were limited to animal models, particularly rats, where mast cell activity could be modulated effectively. However, significant progress in the past five years has led to the development of targeted therapies designed to directly modulate mast cell function in humans.
Mast cells play a central role in chronic urticaria by releasing prepackaged histamine, leukotrienes, and other pro-inflammatory mediators that drive symptoms. These chemicals are responsible for the recurrent and often unpredictable nature of hives, which can be triggered or exacerbated by physical factors such as increased body heat, cold exposure, pressure, or contact with cold water. Many cases remain inadequately controlled with current standard treatments, including antihistamines and omalizumab (Xolair), highlighting a significant unmet therapeutic need.
Recent advancements have focused on targeting the mast cell receptor CDX117. Jasper Pharmaceuticals and Third Harmonic have developed two novel agents aimed at modulating this receptor, offering precise control over mast cell activity. In addition, Celldex Therapeutics has introduced an intravenous formulation that also targets mast cell pathways, potentially providing an effective option for severe or refractory cases of chronic urticaria.
These therapies represent a promising new avenue for addressing challenging cases of chronic hives, especially those unresponsive to existing treatments. By directly targeting the underlying cellular mechanisms, these innovations may provide more consistent and robust symptom relief for patients whose quality of life is significantly impacted by this condition.
Further clinical trials and post-marketing studies will be critical to establish the long-term efficacy and safety profiles of these treatments, as well as to identify optimal patient populations who may benefit the most. Nonetheless, these advancements mark a significant step forward in the therapeutic landscape for chronic urticaria.
If you need to book an appointment for your allergies or asthma, you can book your appointment online, or call (212) 247-7447.